European Patent Office

T 1642/17 (Anti-CXCR7 Ig variable domains/ABLYNX) of 16.11.2020

European Case Law Identifier
ECLI:EP:BA:2020:T164217.20201116
Date of decision
16 November 2020
Case number
T 1642/17
Petition for review of
-
Application number
12713656.2
IPC class
C07K 16/28
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Bispecific anti-CXCR7 immunoglobulin single variable domains
Applicant name
Ablynx N.V.
Opponent name
-
Board
3.3.04
Headnote
-
Keywords
Claims - clarity
Claims - main request (yes)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division for further prosecution on the basis of the set of claims of the main request, i.e. the set of claims attached to the minutes of oral proceedings before the examining division.